Cambridge Investment Research Advisors’s Clover Health Investments CLOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48K | Sell |
17,261
-1,250
| -7% | -$3.48K | ﹤0.01% | 3540 |
|
|
2025
Q1 | $66K | Buy |
18,511
+538
| +3% | +$1.92K | ﹤0.01% | 3387 |
|
|
2024
Q4 | $57K | Buy |
17,973
+47
| +0.3% | +$149 | ﹤0.01% | 3369 |
|
|
2024
Q3 | $51K | Buy |
+17,926
| New | +$51K | ﹤0.01% | 3332 |
|
|
2024
Q1 | – | Sell |
-14,099
| Closed | -$13K | – | 3323 |
|
|
2023
Q4 | $13K | Sell |
14,099
-2,096
| -13% | -$1.93K | ﹤0.01% | 3158 |
|
|
2023
Q3 | $17K | Sell |
16,195
-3,728
| -19% | -$3.91K | ﹤0.01% | 3089 |
|
|
2023
Q2 | $18K | Buy |
19,923
+3,503
| +21% | +$3.17K | ﹤0.01% | 3130 |
|
|
2023
Q1 | $14K | Sell |
16,420
-14,640
| -47% | -$12.5K | ﹤0.01% | 3119 |
|
|
2022
Q4 | $29K | Sell |
31,060
-15,224
| -33% | -$14.2K | ﹤0.01% | 3019 |
|
|
2022
Q3 | $79K | Sell |
46,284
-9,923
| -18% | -$16.9K | ﹤0.01% | 2890 |
|
|
2022
Q2 | $120K | Sell |
56,207
-1,300
| -2% | -$2.78K | ﹤0.01% | 2838 |
|
|
2022
Q1 | $204K | Buy |
57,507
+7,730
| +16% | +$27.4K | ﹤0.01% | 2852 |
|
|
2021
Q4 | $185K | Buy |
49,777
+18,055
| +57% | +$67.1K | ﹤0.01% | 2910 |
|
|
2021
Q3 | $234K | Buy |
31,722
+5,695
| +22% | +$42K | ﹤0.01% | 2668 |
|
|
2021
Q2 | $347K | Buy |
+26,027
| New | +$347K | ﹤0.01% | 2362 |
|
|
2021
Q1 | – | Sell |
-25,864
| Closed | -$434K | – | 2883 |
|
|
2020
Q4 | $434K | Sell |
25,864
-65,431
| -72% | -$1.1M | ﹤0.01% | 1863 |
|
|
2020
Q3 | $1.14M | Buy |
+91,295
| New | +$1.14M | 0.01% | 1113 |
|